Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 135 | 134 | 132 | 135 | 135 |
| Accounts receivable | -36 | -58 | 22 | 60 | -101 |
| Accounts payable and accrued liabilities | -98 | -173 | 450 | -451 | -248 |
| Other Working Capital | 75 | -302 | 570 | -489 | -556 |
| Other Operating Activity | -1,111 | -2,629 | -2,412 | -1,015 | -626 |
| Operating Cash Flow | $-1,035 | $-3,028 | $-1,237 | $-1,760 | $-1,397 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 61 | N/A | N/A | 2,925 | 600 |
| Other Financing Activity | -86 | 0 | 0 | -108 | -335 |
| Financing Cash Flow | $-25 | $N/A | $N/A | $2,817 | $265 |
| Beginning Cash Position | 1,883 | 76 | 1,313 | 255 | 1,386 |
| End Cash Position | 822 | 1,883 | 76 | 1,313 | 255 |
| Net Cash Flow | $-1,061 | $1,807 | $-1,237 | $1,058 | $-1,131 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,035 | -3,028 | -1,237 | -1,760 | -1,397 |
| Free Cash Flow | -1,035 | -3,028 | -1,237 | -1,760 | -1,397 |